JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2951
Rogers Corp
ROG
$2.86B
| $7.04M | ﹤0.01% |
69,254
-7,957
| -10% | -$829K |
2016 Q2
34 quarters
|
|
2952
Burford Capital
BUR
$802M
| $7M | ﹤0.01% |
549,355
+269,928
| +97% | +$3.62M |
2020 Q4
16 quarters
|
|
2953
Pacer US Cash Cows 100 ETF
COWZ
$18.8B
| $7M | ﹤0.01% |
123,910
-301,902
| -71% | -$17.7M |
2023 Q3
5 quarters
|
|
2954
Stewart Information Services
STC
$1.57B
| $6.99M | ﹤0.01% |
103,601
+50,113
| +94% | +$3.58M |
2013 Q2
46 quarters
|
|
2955
CALL
Trip.com Group
TCOM
$24B
| $6.98M | ﹤0.01% |
101,700
+23,600
| +30% | +$1.56M |
2024 Q3
1 quarter
|
|
2956
Eagle Bancorp
EGBN
$865M
| $6.98M | ﹤0.01% |
268,214
+109,960
| +69% | +$2.95M |
2017 Q4
28 quarters
|
|
2957
CALL
Madrigal Pharmaceuticals
MDGL
$11.5B
| $6.97M | ﹤0.01% |
22,600
-15,900
| -41% | -$4.47M |
2022 Q4
8 quarters
|
|
2958
CALL
Verizon
VZ
$191B
| $6.97M | ﹤0.01% |
174,300
-32,200
| -16% | -$1.36M |
2023 Q3
5 quarters
|
|
|
DESP
2959
DELISTED
Despegar.com
DESP
| $6.97M | ﹤0.01% |
362,085
-101,259
| -22% | -$1.59M |
2022 Q1
11 quarters
|
|
|
VRNA
2960
CALL
DELISTED
Verona Pharma
VRNA
| $6.97M | ﹤0.01% |
150,000
+40,000
| +36% | +$1.5M |
2024 Q2
2 quarters
|
|
2961
Delek Logistics
DKL
$3.17B
| $6.95M | ﹤0.01% |
164,556
-79,687
| -33% | -$3.18M |
2018 Q4
24 quarters
|
|
|
BBT
2962
Beacon Financial Corp
BBT
$2.38B
| $6.94M | ﹤0.01% |
243,995
+53,322
| +28% | +$1.54M |
2013 Q2
46 quarters
|
|
2963
Polaris
PII
$3.06B
| $6.9M | ﹤0.01% |
119,695
-1,163,637
| -91% | -$81M |
2013 Q2
46 quarters
|
|
2964
Boston Beer
SAM
$1.72B
| $6.9M | ﹤0.01% |
22,987
-14,309
| -38% | -$4.32M |
2014 Q3
41 quarters
|
|
2965
Rayonier Advanced Materials
RYAM
$482M
| $6.89M | ﹤0.01% |
835,388
+334,497
| +67% | +$2.81M |
2015 Q3
37 quarters
|
|
2966
PUT
Teck Resources
TECK
$33.6B
| $6.89M | ﹤0.01% |
170,000
| – | – |
2024 Q3
1 quarter
|
|
2967
Immunome
IMNM
$2.37B
| $6.89M | ﹤0.01% |
648,610
+624,045
| +2,540% | +$7.54M |
2023 Q4
4 quarters
|
|
2968
PUT
PNC Financial Services
PNC
$88.2B
| $6.88M | ﹤0.01% |
35,700
+18,200
| +104% | +$3.58M |
2021 Q2
14 quarters
|
|
2969
CALL
Avis
CAR
$3.93B
| $6.88M | ﹤0.01% |
+85,400
| New | +$7.79M |
2024 Q4
0 quarters
|
|
2970
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$42.6B
| $6.88M | ﹤0.01% |
50,000
| – | – |
2021 Q4
12 quarters
|
|
2971
Upbound Group
UPBD
$928M
| $6.87M | ﹤0.01% |
235,570
+53,173
| +29% | +$1.65M |
2016 Q1
35 quarters
|
|
2972
VanEck High Yield Muni ETF
HYD
$3.9B
| $6.87M | ﹤0.01% |
132,343
+54,416
| +70% | +$2.85M |
2022 Q1
11 quarters
|
|
2973
CALL
Workday
WDAY
$44.9B
| $6.86M | ﹤0.01% |
26,600
-15,000
| -36% | -$3.83M |
2023 Q2
6 quarters
|
|
2974
PUT
McKesson
MCK
$105B
| $6.84M | ﹤0.01% |
12,000
| – | – |
2024 Q2
2 quarters
|
|
|
DVAX
2975
DELISTED
Dynavax Technologies
DVAX
| $6.81M | ﹤0.01% |
533,594
+328,147
| +160% | +$3.97M |
2016 Q3
33 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.